Celldex Therapeutics (CLDX) Current Assets (2010 - 2026)
Celldex Therapeutics (CLDX) reported Current Assets of $724.93 million for Q2 2026, up 11.8% from $648.4 million a year earlier and up 57.9% from the prior quarter.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Celldex Therapeutics posted Current Assets of $534.66 million, down 28.4% from FY2024.
- Current Assets has a five-year compound annual growth rate of 22.0% (FY2020 to FY2025).
- By year, Current Assets came in at $747.16 million in FY2024 (+73.1%), $431.69 million in FY2023 (+35.9%), $317.69 million in FY2022 (-22.7%) and $410.84 million in FY2021 (+107.7%).
- The Q2 2026 figure ranks as the highest quarterly Current Assets since Q4 2024.
- Year over year, Current Assets gained in three of the last eight quarters, with growth averaging 22.5%.
- The high point for year-over-year Current Assets in five years was Q3 2024 (growth of 216.7%); the low point was Q1 2026 (a decline of 33.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $459.22 million (Q1 2026), $534.66 million (Q4 2025) and $604.34 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Celldex Therapeutics | 2.47 Bn | 2.47 Bn | - | 724.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 724.93 Mn |
| Mar 31, 2026 | 459.22 Mn |
| Dec 31, 2025 | 534.66 Mn |
| Sep 30, 2025 | 604.34 Mn |
| Jun 30, 2025 | 648.40 Mn |
| Mar 31, 2025 | 693.76 Mn |
| Dec 31, 2024 | 747.16 Mn |
| Sep 30, 2024 | 778.84 Mn |
| Jun 30, 2024 | 811.98 Mn |
| Mar 31, 2024 | 835.32 Mn |
| Dec 31, 2023 | 431.69 Mn |
| Sep 30, 2023 | 245.93 Mn |
| Jun 30, 2023 | 264.82 Mn |
| Mar 31, 2023 | 289.60 Mn |
| Dec 31, 2022 | 317.69 Mn |
| Sep 30, 2022 | 334.60 Mn |
| Jun 30, 2022 | 367.98 Mn |
| Mar 31, 2022 | 390.70 Mn |
| Dec 31, 2021 | 410.84 Mn |
| Sep 30, 2021 | 426.56 Mn |
API Access
Celldex Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=CLDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "CLDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=CLDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();